日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency.

CAR 改造的 PIK3CD 碱基编辑增强了 T 细胞的抗肿瘤效力。

Bucher Philip, Brückner Nadine, Kortendieck Jule, Grimm Melanie, Schleicher Jan T, Bartels Karlotta, Hardy Steffen, Rausch Martina, Wurzer Hannah, Thiemann Meike, May Celina, Mitstorfer Mara, Letzgus Dennis, Quach Julia, Schneider Carolin, Ispan Denis A, Gonzalez-Menendez Irene, Jain Nayan, Ho Yu-Jui, Chen Jiangqing, Sánchez-Rivera Francisco J, Sun Jie, Quintanilla-Martinez Leticia, Trautwein Christoph, Weigelin Bettina, Claassen Manfred, Sadelain Michel, Feucht Judith, Leibold Josef

Modeling immunotherapies in live 3D human cancer tissue bioreactors

在活体3D人类癌组织生物反应器中模拟免疫疗法

Zhang, Yizheng; Foth, Ivan; Makky, Ahmad; Bucher, Philip; Grimm, Melanie; Bruch, Peter-Martin; Hagelstein, Ilona; Dietrich, Sascha; Leibold, Josef; Flatz, Lukas; Feucht, Judith; Becker, Sven; Schürch, Christian M

A Complementarity-Based Approach to De Novo Binder Design.

基于互补性的全新粘合剂设计方法

Maksymenko Kateryna, Hatskovska Valeriia, Coles Murray, Aghaallaei Narges, Pashkovskaia Natalia, Borbarán-Bravo Natalia, Pilz Matteo, Bucher Philip, Volz Mareike, Pereira Joana, Hartmann Marcus D, Tabatabai Ghazaleh, Feucht Judith, Liebau Stefan, Müller Patrick, Lupas Andrei N, Skokowa Julia, ElGamacy Mohammad

Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress

在弥漫性大B细胞淋巴瘤(DLBCL)中,谷氨酰胺酶-1的抑制可通过促进氧化应激增强维奈托克诱导的抗肿瘤活性。

Gomez Solsona, Beatriz; Horn, Heike; Schmitt, Anja; Xu, Wendan; Bucher, Philip; Heinrich, Aylin; Kalmbach, Sabrina; Kreienkamp, Nina; Franke, Maik; Wimmers, Florian; Schuhknecht, Laurentz; Rosenwald, Andreas; Zampieri, Mattia; Ott, German; Lenz, Georg; Schulze-Osthoff, Klaus; Hailfinger, Stephan